Sanofi
SNYNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $114,742,485 | $113,170,400 | $112,565,705 | $109,043,401 |
| - Cash | $7,441,000 | $8,710,000 | $12,736,000 | $10,098,000 |
| + Debt | $17,906,000 | $18,422,000 | $21,212,000 | $22,414,000 |
| Enterprise Value | $125,207,485 | $122,882,400 | $121,041,705 | $121,359,401 |
| Revenue | $44,286,000 | $46,444,000 | $40,304,000 | $39,175,000 |
| % Growth | -4.6% | 15.2% | 2.9% | – |
| Gross Profit | $31,081,000 | $32,208,000 | $31,694,000 | $26,920,000 |
| % Margin | 70.2% | 69.3% | 78.6% | 68.7% |
| EBITDA | $11,033,000 | $11,076,000 | $13,510,000 | $11,251,000 |
| % Margin | 24.9% | 23.8% | 33.5% | 28.7% |
| Net Income | $5,560,000 | $5,400,000 | $8,371,000 | $6,223,000 |
| % Margin | 12.6% | 11.6% | 20.8% | 15.9% |
| EPS Diluted | 4.43 | 4.3 | 6.66 | 4.95 |
| % Growth | 3% | -35.4% | 34.5% | – |
| Operating Cash Flow | $9,081,000 | $10,258,000 | $10,526,000 | $10,522,000 |
| Capital Expenditures | -$3,195,000 | -$1,619,000 | -$2,201,000 | -$2,043,000 |
| Free Cash Flow | $5,886,000 | $8,639,000 | $8,325,000 | $8,479,000 |